ArticleCureus2026
Spectrum of Cytogenetic and Molecular Abnormalities in Disorders of Sex Development: A Retrospective Observational Study From Western India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDisorders of sex development (DSD) are a social and medical emergency. A thorough history, detailed clinical examination, and appropriate investigations will help to identify the aetiology of DSD. But still, in most cases, the exact aetiology is not reached. Reaching a definite and firm diagnosis with the help of genetic testing is vital for the long-term management of DSD patients.
methodsWe conducted a hospital record-based, retrospective cross-sectional study of 20 children with DSD aged 0-14 years who attended the paediatric endocrine clinic at our institute from February 2022 to July 2024. Clinical, hormonal, radiological, cytogenetic, molecular and outcome data were analysed.
resultsDuring the study period, 20 children were diagnosed with DSD at our institute. Their age range was between 0 and 14 years. Among them, 6/20 patients were diagnosed with 46, XX DSD, 12/20 with 46, XY DSD and 2/20 with sex chromosomal DSD. Cytogenetic analysis and whole-exome sequencing were done in all patients. Seven patients (35%) showed significant pathogenic variants in genes such as RSPO1, CYP21A2, CYP19A1, WT1, and SRD5A2. Out of seven genetically confirmed DSD patients, in only one was the gender of rearing changed after the diagnosis.
conclusionManagement of DSD involves a multidisciplinary team from different specialities. The present study focuses on the cytogenetic and molecular diagnostic findings in children with atypical genitalia, which can be an efficient tool in the clinical diagnosis and management of DSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.